Beleggen.nl
Uitgebreid zoeken
Markt MonitorMarkt Monitor

BioPharma Terug naar discussie overzicht

Pegasus Wireless - PGWC

1.162 Posts
Pagina: 1 2 3 4 5 6 ... 59 »» | Laatste | Omlaag ↓
  1. [verwijderd] 26 september 2006 14:05

    • [verwijderd]

      Lid sinds: 01 jan 0001

      Laatste bezoek: 01 jan 0001

    • Aanbevelingen

      Ontvangen: 0

      Gegeven: 0

    •    Aantal posts: 0

    Slachtoffer van Short Selling. Zij zijn het beu dat de koers sinds mei omlaag gemanipuleerd wordt ( van 19 naar 1 $ ) en verhuizen daarom vrijwillig naar de OTC beurs, niettegenstaande ze voldoen aan alle Nasdaq regels.

    Pegasus Is De-Listing
    Liz Moyer, 09.25.06, 10:45 PM ET

    Jasper Knabb and his streaming video technology is about to beat Steve Jobs to the punch.

    But before that, the chief executive of Pegasus Wireless, a Freemont, Calif., wireless equipment maker, has to contend with forces that have hammered down the company’s stock by more than 90% since May in an aggressive and seemingly relentless bear raid.

    Late Monday, Pegasus announced it was applying voluntarily to de-list its stock from the Nasdaq national market, with plans to move to another national market or the over-the-counter market by the end of October.

    The move comes after an attack of short selling that began shortly after the company’s Nasdaq listing in April and accelerated through the summer. Right now, shares of Pegasus are trading around $1.07, down from $18.60 in mid-May. This comes despite positive earnings in June and the announcement that the company would soon unveil patent-pending wireless video streaming technology for consumer use.

    The technology that Knabb is scheduled to unveil days from now, he says, will beat Apple Computer to market by several months.

    Pegasus' patent-pending device allows consumers to wirelessly stream DVD-quality video content from the Internet in real-time to a TV elsewhere in their house. Last week, Jobs, Apple's chief executive, announced that his company would be ready to unveil similar technology for home use early next year.

    Meanwhile, Pegasus shares are under constant attack. What’s striking about the activity affecting the company’s stock are the concurrent volume spikes in trading, the build-up of short interest from almost nothing to about half the available float, and the sharp decline in the price. All of this has occurred in the last three months.

    Pegasus said in a statement that that it is in compliance with all the Nasdaq Global Market listing requirements. Knabb said, explaining the move, “Taking into consideration current market environments and trading patterns over the last six months, the board has determined that maintaining the listing of Pegasus Wireless’ common stock on Nasdaq no longer serves the best interests of the company and its stockholders.”

    Spokespersons for Nasdaq were not immediately available Monday night.

    The steepest declines in Pegasus shares have come in the last month, after a series of negative news articles taking Knabb to task for his background and his prior business associations.

    The stock's decline also coincides with the publication of 11 negative research notes from July through August by well-known short-seller Manuel Asensio, who runs his own research firm, Asensio & Co.

    An e-mail message to Asensio’s firm earlier on Monday was not answered.

    Pegasus shares are down 86% since Aug. 23. That's bad news not just for Knabb, who has sunk some $16.5 million of his own money into the company and given up a salary and cash bonus in favor of stock grants. Institutional holders as of June 30 included Barclays Global, Goldman Sachs, Deutsche Bank, Vanguard, Mellon Financial, and the Ohio Public Employees Retirement System.

    Knabb invited criticism when he announced in early August that he would pay a warrant to shareholders as a way of saying thanks to those who had stuck around while the price dropped during the early summer.

    From the May 5 peak of $18.60 a share, the price had dropped some 67% by the time he announced the warrant offer on Aug. 4.

    But the warrant would only be paid to registered shareholders. That meant brokerages holding the shares for clients in "street name" would have to submit lists to Pegasus' transfer agent to match up their clients with the shares they had on record. The warrant was not transferable, meaning it would only be paid to beneficial shareholders, not to the brokerages to distribute to clients.

    Some accused Knabb of trying to manipulate his stock by structuring the warrant offer this way. It had the effect of forcing anyone who lent the stock out to call it back in, forcing shorts to cover their positions. Such a quick buy-in--the deadline was originally Aug. 11--can push the shares up as the shorts scramble for shares to cover.

    Knabb has denied any such intent to force his stock higher.

    In trying to sort out the information coming to Pegasus’ transfer agent from brokers and information on the company’s stock held at the Depository Trust & Clearing Corp., it became clear that there was a problem. Brokers are reporting more shares--3 million to 22 million, depending on what data is examined--than exist.

    Such share discrepancies can result from innocent errors or from something more: naked short sales of Pegasus stock, meaning a short-seller has not properly gotten dibs on shares to borrow before selling. Naked short-selling can result in the same share being lent to more than one trader, creating phantom share entitlements.

    In simple supply and demand economics, artificially increasing supply will push down the price of even the strongest of shares.

    By mid-August, it was becoming increasingly obvious that traders were betting heavily on a decline in Pegasus. Short interest reported by Nasdaq rose to 8.3 million in August from 5.1 million in July. It was 8.3 million for September. The Nasdaq reports short interest on the fifth or six of the month.

    Volume on Pegasus soared from basically nothing at the beginning of 2006 to more than 1 million trades a day. On Sept. 5, more than 17 million shares traded hands. Pegasus has a free float of about 16 million shares.

    On Aug. 17, Pegasus also joined a list of Nasdaq stocks that have the most trade settlement failures. It has stayed there since.

    tinyurl.com/rf45s
  6. [verwijderd] 26 september 2006 21:42

    • [verwijderd]

      Lid sinds: 01 jan 0001

      Laatste bezoek: 01 jan 0001

    • Aanbevelingen

      Ontvangen: 0

      Gegeven: 0

    •    Aantal posts: 0

    quote:

    -Anna- schreef:

    Ik denk dat het wel een klein gokje waard is maar meestal na zon daling kan er de tweede dag ook nog wel eens 10% af gaan.
    En waarschijnlijk nog eens een daling als hij op de OTC terecht komt. Het is inderdaad een eigenaardige manier om zich te verdedigen tegen de shorts. Op die manier kom je ze echt tegemoet. Link volgens mij.
  7. [verwijderd] 26 september 2006 21:48

    • [verwijderd]

      Lid sinds: 01 jan 0001

      Laatste bezoek: 01 jan 0001

    • Aanbevelingen

      Ontvangen: 0

      Gegeven: 0

    •    Aantal posts: 0

    ik sluit me aan bij crackedtooth, lees het artikel eens wat in de link erbij zit.
    Ik had hem al aangevraagd bij Binck (morgen toegevoegd), echter ik blijf er toch maar vanaf..
  16. [verwijderd] 27 september 2006 19:32

    • [verwijderd]

      Lid sinds: 01 jan 0001

      Laatste bezoek: 01 jan 0001

    • Aanbevelingen

      Ontvangen: 0

      Gegeven: 0

    •    Aantal posts: 0

    NEW YORK, Sept 3 (Reuters) - Shares of Pegasus Wireless Corp. (PGWC.O: Quote, Profile, Research) are unlikely to recover from their recent decline unless the company introduces new technology, Barron's reported in its Sept. 4th edition.

    Pegasus, which makes wireless routers for streaming audio and video, has acquired five companies, and reverse-merged with two others, over the past two years.

    Investors, who acquired restricted Pegasus shares in the deals, have been unable to sell them once the restrictions were lifted, and one has sued the company, the business news weekly reported.

    The company's chairman and a board member recently resigned, Barron's said. Pegasus shares closed Friday at $2.38, compared to their May high of about $19 per share.

  17. [verwijderd] 27 september 2006 19:51

    • [verwijderd]

      Lid sinds: 01 jan 0001

      Laatste bezoek: 01 jan 0001

    • Aanbevelingen

      Ontvangen: 0

      Gegeven: 0

    •    Aantal posts: 0

    quote:

    welshterrier schreef:

    wanneer een aandeel in de OTC komt, zijn ze dan nog makkelijk te verkopen, bij Binck bv??
    Volgens mij kan het dan nog wel, misschien moet het wel telefonisch dan. Zou je even moeten vragen.
    Ik kan me herinneren dat binck ooit belooft heeft otc aandelen beschikbaar te willen maken, maar volgens mij gaan ze dat niet meer doen.
  18. [verwijderd] 27 september 2006 19:54

    • [verwijderd]

      Lid sinds: 01 jan 0001

      Laatste bezoek: 01 jan 0001

    • Aanbevelingen

      Ontvangen: 0

      Gegeven: 0

    •    Aantal posts: 0

    nee kan je wel verkopen

    hmm o,76 zal hem niet meer worden, probeer het toch kort..

    gedachte..

    delisting niet bedoeld om daarna op de daling zelf bedrijf volledig terug te kopen voor prikkie?

    of om zo remaining shorts te burnen?

    vertrouw motieven voor geen meter
  19. [verwijderd] 27 september 2006 19:59

    • [verwijderd]

      Lid sinds: 01 jan 0001

      Laatste bezoek: 01 jan 0001

    • Aanbevelingen

      Ontvangen: 0

      Gegeven: 0

    •    Aantal posts: 0

    quote:

    crackedtooth schreef:

    nee kan je wel verkopen

    hmm o,76 zal hem niet meer worden, probeer het toch kort..

    gedachte..

    delisting niet bedoeld om daarna op de daling zelf bedrijf volledig terug te kopen voor prikkie?

    of om zo remaining shorts te burnen?

    vertrouw motieven voor geen meter
    Wat ik net op yahoo las is dat het oa te maken kan hebben met market makers en optie mms. Daar zijn ze dan vanaf.
    Motief lijkt me duidelijk, proberen af te komen van de short sellers.

    De vraag is meer gaan ze niet failliet of hebben ze een product wat goed gaat verkopen. Toch?
  21. [verwijderd] 27 september 2006 20:12

    • [verwijderd]

      Lid sinds: 01 jan 0001

      Laatste bezoek: 01 jan 0001

    • Aanbevelingen

      Ontvangen: 0

      Gegeven: 0

    •    Aantal posts: 0

    Als ik naar de omzet ten opzichte van de marktwaarde van het bedrijf kijk zit dat nu behoorlijk scheef.

    Revenue (ttm): 82.44M
    Revenue Per Share (ttm): 0.973
    Market Cap (intraday): 60.26M
    Diluted EPS (ttm): 0.015

    Vond net dit nog:

    biz.yahoo.com/bw/060824/2006082400550...

    Is morgen.

    biz.yahoo.com/bw/060717/2006071700537...

    Lancering nieuwe product is 1 oktober. Misschien dat het uitgesteld is en dan het bedrijf productie problemen heeft?

    Ik kan echt niets echt negatief vinden, behalve de daling, maar dat kan juist een koop kans zijn. Ik ben toch wel erg nieuwsgierig nu wat er gaat gebeuren.
1.162 Posts
Pagina: 1 2 3 4 5 6 ... 59 »» | Laatste |Omhoog ↑

Neem deel aan de discussie

Word nu gratis lid van Beleggen.nl

Al abonnee? Log in

Direct naar Forum

Zoek alfabetisch op forum

  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
Forum # Topics # Posts
Aalberts 466 7.001
AB InBev 2 5.481
Abionyx Pharma 2 29
Ablynx 43 13.356
ABN AMRO 1.582 51.192
ABO-Group 1 22
Acacia Pharma 9 24.692
Accell Group 151 4.132
Accentis 2 264
Accsys Technologies 23 10.501
ACCSYS TECHNOLOGIES PLC 218 11.686
Ackermans & van Haaren 1 188
ADMA Biologics 1 34
Adomos 1 126
AdUX 2 457
Adyen 14 17.647
Aedifica 3 901
Aegon 3.258 322.648
AFC Ajax 538 7.086
Affimed NV 2 6.287
ageas 5.844 109.884
Agfa-Gevaert 14 2.048
Ahold 3.538 74.292
Air France - KLM 1.025 34.991
AIRBUS 1 11
Airspray 511 1.258
Akka Technologies 1 18
AkzoNobel 467 13.035
Alfen 16 24.319
Allfunds Group 4 1.468
Almunda Professionals (vh Novisource) 651 4.251
Alpha Pro Tech 1 17
Alphabet Inc. 1 405
Altice 106 51.198
Alumexx ((Voorheen Phelix (voorheen Inverko)) 8.486 114.812
AM 228 684
Amarin Corporation 1 133
Amerikaanse aandelen 3.835 242.709
AMG 971 133.042
AMS 3 73
Amsterdam Commodities 305 6.686
AMT Holding 199 7.047
Anavex Life Sciences Corp 2 482
Antonov 22.632 153.605
Aperam 92 14.900
Apollo Alternative Assets 1 17
Apple 5 380
Arcadis 252 8.731
Arcelor Mittal 2.033 320.549
Archos 1 1
Arcona Property Fund 1 286
arGEN-X 17 10.288
Aroundtown SA 1 219
Arrowhead Research 5 9.715
Ascencio 1 26
ASIT biotech 2 697
ASMI 4.108 39.078
ASML 1.766 105.976
ASR Nederland 21 4.451
ATAI Life Sciences 1 7
Atenor Group 1 469
Athlon Group 121 176
Atrium European Real Estate 2 199
Auplata 1 55
Avantium 32 13.609
Axsome Therapeutics 1 177
Azelis Group 1 64
Azerion 7 3.390